LIFEVANTAGE CORP Payments of Financing Costs
LIFEVANTAGE CORP (LFVN) reported Payments of Financing Costs of $12.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfFinancingCosts · last filed 2026-08-27
- LIFEVANTAGE CORP payments of financing costs for the quarter ending 2026-06-30 was $0.00.
- LIFEVANTAGE CORP payments of financing costs for the quarter ending 2026-03-31 was $0.00.
- LIFEVANTAGE CORP payments of financing costs for the quarter ending 2025-12-31 was $0.00.
- LIFEVANTAGE CORP payments of financing costs for the quarter ending 2025-09-30 was $12.00K.
- LIFEVANTAGE CORP payments of financing costs for fiscal 2026 was $12.00K.
- LIFEVANTAGE CORP payments of financing costs for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- LIFEVANTAGE CORP payments of financing costs for fiscal 2024 was $97.00K.
- LIFEVANTAGE CORP payments of financing costs for fiscal 2023 was $0.00.
| Period end | Payments of Financing Costs 3 month | Payments of Financing Costs 6 month | Payments of Financing Costs 9 month | Payments of Financing Costs 9 month as first filed | Payments of Financing Costs 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $0.00 derived: sum of 2 quarters · filed 2026-08-27 | $0.00 derived: sum of 3 quarters · filed 2026-08-27 | $12.00K 10-K · filed 2026-08-27 | |
| 2026-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $12.00K 10-Q · filed 2026-05-06 | $12.00K derived: sum of 4 quarters · filed 2026-08-27 | |
| 2025-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | $12.00K 10-Q · filed 2026-02-04 | $12.00K derived: sum of 3 quarters · filed 2026-08-27 | $12.00K derived: sum of 4 quarters · filed 2026-08-27 | |
| 2025-09-30 | $12.00K 10-Q · filed 2025-11-04 | $12.00K derived: sum of 2 quarters · filed 2026-08-27 | $12.00K derived: sum of 3 quarters · filed 2026-08-27 | $12.00K derived: sum of 4 quarters · filed 2026-08-27 | |
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $0.00 derived: sum of 2 quarters · filed 2026-08-27 | $0.00 derived: sum of 3 quarters · filed 2026-08-27 | $0.00 10-K · filed 2026-08-27 | |
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $0.00 10-Q · filed 2026-05-06 | ||
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-04 | $0.00 10-Q · filed 2026-02-04 | |||
| 2024-09-30 | $0.00 10-Q · filed 2025-11-04 | ||||
| 2024-06-30 | $97.00K 10-K · filed 2025-09-04 | ||||
| 2023-06-30 | $0.00 10-K · filed 2024-08-28 | ||||
| 2020-06-30 | $0.00 10-K · filed 2020-08-18 | ||||
| 2019-06-30 | $0.00 10-K · filed 2020-08-18 | ||||
| 2018-06-30 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-18 | $60.00K 10-K · filed 2020-08-18 | |||
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 | ||||
| 2017-06-30 | -$1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-14 | $0.00 10-K · filed 2019-08-14 | |||
| 2017-03-31 | $1.38M 10-Q · filed 2018-05-09 | $0.00 10-Q · filed 2017-05-10 | |||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-15 | $99.00K 10-K · filed 2018-08-15 | |||
| 2016-03-31 | $99.00K 10-Q · filed 2017-05-10 | ||||
| 2015-06-30 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-09-07 | $0.00 derived: sum of 2 quarters · filed 2017-09-07 | $0.00 10-K · filed 2017-09-07 | ||
| 2015-03-31 | $0.00 derived: 10-Q/A 9 month − 10-Q 6 month · filed 2016-07-19 | $0.00 10-Q/A · filed 2016-07-19 | |||
| 2014-12-31 | $0.00 10-Q · filed 2015-02-04 | ||||
| 2014-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-12 | $0.00 derived: sum of 2 quarters · filed 2016-12-12 | $1.51M 10-K · filed 2016-12-12 | ||
| 2014-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | $1.51M 10-Q · filed 2015-05-06 | |||
| 2013-12-31 | $1.51M 10-Q · filed 2015-02-04 | ||||
| 2013-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-01 | $0.00 derived: sum of 2 quarters · filed 2015-09-01 | $0.00 10-K · filed 2015-09-01 | ||
| 2013-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-06 | $0.00 10-Q · filed 2014-05-06 | |||
| 2012-12-31 | $0.00 10-Q · filed 2014-02-06 | ||||
| 2012-06-30 | $0.00 10-K · filed 2014-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |